Current status of systemic intravenous radiopharmaceuticals for the treatment of painful metastatic bone disease.

  • A N Serafini
  • Published 1994 in
    International journal of radiation oncology…


PURPOSE Intractable bone pain secondary to bone metastasis from prostate, lung, breast, and other malignancies is a major problem in the management of the oncological patient. Because a number of factors are implicated in the pathophysiology of bone pain, a multidisciplinary approach in its assessment and treatment is often required. Treatment often… (More)


  • Presentations referencing similar topics